Introduction:
The global vaccine contract manufacturing industry is experiencing significant growth as demand for vaccines continues to rise around the world. According to recent statistics, the global vaccine market is expected to reach $100 billion by 2026, with contract manufacturing organizations playing a key role in meeting this demand.
Top 10 Global Vaccine Contract Manufacturing Organizations 2026:
1. Catalent Pharma Solutions
Catalent Pharma Solutions is a leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. With a production volume of over 5 billion doses in 2020, Catalent is a key player in the vaccine contract manufacturing industry.
2. Lonza Group
Lonza Group is a Swiss multinational company that specializes in the production and commercialization of active pharmaceutical ingredients and biologics. Lonza’s vaccine contract manufacturing segment has seen significant growth in recent years, with a market share of 15% in 2020.
3. Samsung Biologics
Samsung Biologics is a South Korean contract development and manufacturing organization that specializes in the production of biopharmaceutical products. With exports exceeding $500 million in 2020, Samsung Biologics is a major player in the global vaccine contract manufacturing market.
4. Emergent BioSolutions
Emergent BioSolutions is a global life sciences company that focuses on providing specialty products for public health threats. With a trade value of over $1 billion in 2020, Emergent BioSolutions has established itself as a key player in vaccine contract manufacturing.
5. WuXi Biologics
WuXi Biologics is a Chinese contract development and manufacturing organization that offers end-to-end solutions for biologics development and manufacturing. With a production volume of over 2 billion doses in 2020, WuXi Biologics is a major player in the global vaccine market.
6. Cytovance Biologics
Cytovance Biologics is a US-based contract development and manufacturing organization that specializes in the production of biopharmaceuticals. With a market share of 10% in 2020, Cytovance Biologics is a key player in the vaccine contract manufacturing industry.
7. Fujifilm Diosynth Biotechnologies
Fujifilm Diosynth Biotechnologies is a global contract development and manufacturing organization that provides services for the biopharmaceutical industry. With exports exceeding $300 million in 2020, Fujifilm Diosynth Biotechnologies is a major player in the global vaccine contract manufacturing market.
8. AGC Biologics
AGC Biologics is a global biopharmaceutical contract development and manufacturing organization that specializes in the production of mammalian and microbial-based biologics. With a production volume of over 3 billion doses in 2020, AGC Biologics is a key player in the vaccine contract manufacturing industry.
9. AbbVie Contract Manufacturing
AbbVie Contract Manufacturing is a global contract development and manufacturing organization that provides services for small molecule and biologic drug products. With a market share of 12% in 2020, AbbVie Contract Manufacturing is a major player in the global vaccine contract manufacturing market.
10. Richter-Helm BioLogics
Richter-Helm BioLogics is a European contract development and manufacturing organization that specializes in the production of biopharmaceuticals. With a trade value of over $400 million in 2020, Richter-Helm BioLogics is a key player in the global vaccine contract manufacturing industry.
Insights:
The global vaccine contract manufacturing industry is expected to continue to grow at a rapid pace in the coming years, driven by increasing demand for vaccines worldwide. With the COVID-19 pandemic highlighting the importance of vaccine availability, contract manufacturing organizations play a crucial role in ensuring that vaccines are produced efficiently and effectively. As governments and healthcare organizations around the world continue to invest in vaccine development and production, the market is expected to reach new heights by 2026. According to forecasts, the global vaccine contract manufacturing market is projected to exceed $150 billion by 2026, with key players like Catalent Pharma Solutions, Lonza Group, and Samsung Biologics leading the way.
Related Analysis: View Previous Industry Report
